Industry News
Excerpt from the announcement: TORONTO, ON — May 14, 2020 – The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, announced today a Canada-wide call for applications from companies for its Early Adopter Health Network (EAHN™) to address COVID-19. Click the button below to read the article:…
Read More
Excerpt from the article: “As SARS-CoV-2, the deadly coronavirus responsible for COVID-19, spread from Wuhan, China, to nearly every country around the globe, dozens of companies rushed to develop a vaccine against the novel virus. The Coalition for Epidemic Preparedness Innovations (CEPI), a leading global funder of vaccine development, put its vote of confidence in…
Read More
Excerpt from the announcement: “The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that…
Read More
GIOSTAR Announces FDA Approval Under Compassionate Use for a COVID-19 Clinical Trial with Stem Cells
Excerpt from the press release: SAN DIEGO, May 4, 2020 /PRNewswire/ — Global Institute of Stem Cell Therapy and Research (GIOSTAR), the worldwide leader in stem cell research, is pleased to announce that they have received an approval for a COVID-19 clinical trial, led by their Medical Director Dr. Prabhat Soni. GIOSTAR will conduct the…
Read More
Excerpt from the article: “There is no denying that the COVID-19 pandemic has spurred tremendous innovation across our industry. Even more impressive is the pace at which we have been able to implement technology solutions that can facilitate continued progress in our critical activities and trials. Most importantly, the expansion of telemedicine and virtual solutions…
Read More
Excerpt from the article: “Gilead Sciences’ experimental drug remdesivir has been gaining traction as a potential Covid-19 treatment, and late last week scored an emergency use authorization from federal regulators for it to be used in patients with the condition.” Click the button below to read the article and watch the video: Continue Reading The…
Read More
Excerpt from the article: “There is some good news in the fight against the novel coronavirus. More than 100,000 people in the United States who were infected with the virus have since recovered and in many of those who’ve recovered, doctors have discovered coronavirus antibodies, proteins that can potentially be used to fight the virus.…
Read More
Excerpt from the article: “VANCOUVER—A Canadian biotech company says it’s well on its way to developing a treatment for COVID-19 that could help save the lives of those most vulnerable to the virus. And Carl Hansen’s AbCellera Biologics Inc. now has a $175-million vote of confidence from the federal government.” Click the button below to…
Read More
Excerpt from the article: “Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic.” Click the button below to read the article:…
Read More
Excerpt from the article: A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19. “The animals were infected with the novel coronavirus, SARS-CoV-2. Data announced by the National Institutes of Health (NIH) revealed a significant decrease in clinical disease and reduced lung…
Read More